The beauty industry is undergoing a significant transformation, driven by scientific advances, evolving consumer expectations ...

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...